Clinical trial · Interventional
Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
NCT07035418CI-TRIAL-00104222recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent Behavior | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Clinical Decision-Making Scenarios and Preferences Assessment | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- AYA Decision-Making Role Assessment
- description
- Participants will complete an electronic socio-demographic questionnaire followed by a set of hypothetical clinical decision-making scenarios to assess preferred decision-making roles and involvement of healthcare providers and family/friends. Responses will inform understanding of facilitators and barriers to shared decision-making.
- interventionNames
- Behavioral: Clinical Decision-Making Scenarios and Preferences Assessment
Primary outcomes (1)
- measure
- Distribution of Decision-Making Roles in Clinical Scenarios
- timeFrame
- Within 2 weeks of survey link delivery
- description
- Proportion of participants who select an active, collaborative, or passive role in hypothetical clinical decision-making scenarios. Each role will be counted and compared across participant subgroups.
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * Age (15-29 years) * Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year) * Speaks English * Reads English * Cognitively and physically able to participate Exclusion Criteria: * Unable to participate in study due to developmental delay or developmental disorder
References
Publications (0)
Data not yet available
No reference posted for this study.